Navigation Links
Penn Medicine Contest Challenges Philadelphians to Help Save Lives With Their Cell Phones
Date:12/10/2011

PHILADELPHIA, Dec. 10, 2011 /PRNewswire-USNewswire/ -- A group of Penn Medicine researchers is set to save lives with cell phone cameras -- and they're challenging the public to help. The MyHeartMap Challenge, a month-long contest slated to take place beginning in mid January, will send thousands of Philadelphians to the streets and to social media sites to locate as many automated external defibrillators (AEDs) as they can. The contest is just a first step in what the Penn team hopes will grow to become a nationwide, crowd-sourced AED registry project that will put the lifesaving devices in the hands of anyone, anywhere, anytime.

Armed with a free app installed on their mobile phones, contest participants will snap pictures of the lifesaving devices -- which are used to restore cardiac arrest victims' hearts to their normal rhythm - wherever they find them in public places around the city. Participants will use the app to geotag the photos with their location and details about the device like its manufacturer. Then, they'll send them to the research team via the app itself or the project's web site. The data collected will be used to create an updated app linking locations of all public AEDs in the city with a person's GPS coordinates to help them locate the nearest AED during an emergency.

The stakes are high: The person or team who finds the most AEDs during the contest will win $10,000, and the fruits of their efforts could save lives in the critical minutes following cardiac arrest. Participants who find various pre-located "golden ticket" AEDs around the city will also win $50 for identifying each of those devices." The project is modeled after the DARPA Network Challenge, a crowd-sourcing experiment in which social media users raced to be the first to submit the locations of 10 moored, 8-foot, red, weather balloons at 10 fixed locations throughout the United States.

"More and more, scientists are learning that we can benefit from
'/>"/>

SOURCE Perelman School of Medicine at the University of Pennsylvania
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The New England Journal of Medicine Publishes Study Showing LigoCytes Norovirus Vaccine Demonstrates Protection Against Illness
2. Combining Express Scripts and Medco Health Solutions Will Help Protect Americans From the Rising Costs of Prescription Medicine
3. Avanafil Data Presented at the European Society of Sexual Medicine Meeting
4. Beyond Lucid Technologies Advances Telemedicine for EMS Providers
5. European Medicines Agencys (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012
6. Heart IT and Johns Hopkins Medicine Announce the Award of NIH Grant to Include Images in the Nationwide Health Information Network (NHIN)
7. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
8. Sea Grant and AVMA Join Forces to Raise Awareness on Medicine Disposal
9. Gaylord Sleep Medicine Expands Sleep Apnea Management Program
10. XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation
11. Third Aesthetic Plastic Surgery & Anti-Aging Medicine: The Next Generation Symposium Will Feature Newest Advancements in Dermal Fillers and Energy Based Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Therapeutics (Nasdaq: NKTR ) will announce its financial results ... August 5, 2015, after the close of U.S.-based financial markets. ... host a conference call to review the results beginning at ... The press release and a live audio-only Webcast ... that is posted on the home page and Investor Relations ...
(Date:7/29/2015)... 29, 2015  Ascendis Pharma A/S (Nasdaq: ASND ... innovative TransCon technology to address significant unmet medical needs, ... on July 30, 2015, at 9:00 a.m. Eastern Time ... pediatric study of once-weekly TransCon Growth Hormone. The conference ... before the market opens on July 30, 2015. ...
(Date:7/29/2015)... 2015  STAAR Surgical Company (NASDAQ: STAA ), a ... systems for the eye today reported financial results for the ... Quarter Overview , Net Sales of $18.7 Million Down ... Impact of $2.1 Million from the Weakening Euro and Yen ... in China , APAC Sales Down 1% Including Korea ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3Ascendis Pharma A/S to Report Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone and Host Conference Call on Thursday, July 30, 2015 at 9:00 a.m. Eastern Time 2STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24
... Data from Phase 1 Clinical Trial of SNS-595 ... FRANCISCO, Calif., June 11, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, ... of the company's,anti-cancer product candidates, SNS-595 and SNS-032, ... (EHA) in Vienna,Austria. , Interim Results from Sunesis' ...
... 2007 (MARKET WIRE via COMTEX News Network),-- ... of Endo,Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), has ... placebo-controlled,clinical trial evaluating Frova (frovatriptan succinate) 2.5 ... women with,difficult-to-treat menstrual migraine (MM). The data ...
Cached Medicine Technology:Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7
(Date:7/29/2015)... California (PRWEB) , ... July 29, 2015 , ... Conventional ... sell, and trade goods and services may be able to unlock mysteries about the ... Claremont Graduate University , Boston University, and Columbia University. , The findings, published July ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... have become increasingly aware of the impact drinking and substance abuse is having ... illness. Financial loss is tagged in the billions per year. [1] Will Wesch, ...
(Date:7/29/2015)... ... ... Core Organizer ” was featured on NewsWatch as part of its monthly AppWatch, which ... Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the ... , Wouldn’t it be great if everyone could be a little more organized? Well ...
(Date:7/29/2015)... ... July 29, 2015 , ... More ... and service providers of children living with autism will converge upon Penn State ... demographic. , The National Autism Conference will be held Aug. 3-6 at ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... According to ... flies revealed a gene which is directly responsible for stimulating and perpetuating alcohol use ... in the journal entitled Proceedings of the National academy of Sciences, and has given ...
Breaking Medicine News(10 mins):Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University